BTK and PI3K Inhibitors Reveal Synergistic Inhibitory Anti-Tumoral Effects in Canine Diffuse Large B-Cell Lymphoma Cells. The gene discussed is PIK3CB; the disease is diffuse large B-cell lymphoma.